Skip to main content
InPharmacy - return to the homepage InPharmacy logo
  • Search
  • Visit InPharmacy on Linked In
  • Visit InPharmacy on Twitter
  • Visit InPharmacy on Facebook
  • Visit InPharmacy on YouTube
Visit the
National Pharmacy Association National Pharmacy Association

Main navigation

  • NPA News
  • Your Pharmacy
  • Member Benefits
  • Topics
Quick links:
  • Home
  • Categories
  • Your Pharmacy
  • Advice & Support
Patient Safety
England
Pharmacy Owner / Director
Superintendent / Deputy Superintendent Pharmacist
LPC Representative

Medication Safety Officer report Q1 2021

Share on
  • Whatsapp
  • Twitter
  • Facebook
  • Linked in
  • Mail
  • Print
Open-access content Monday 1st March 2021 — updated 5.02pm, Tuesday 2nd November 2021
web_kickstarter_credit_wavebreakmedia_shutterstock_255794938.png

Medication Safety update presenting NPA's analysis of patient safety incidents reported during the first quarter of 2021 – access the full report here

Included in the NPA Q1 2021 medication safety update:

  • Analysis of patient safety incidents reported during Q1 2021
  • Look alike sound alike (LASA) errors analysis
  • Use of chloramphenicol eye drops in children under two years of age
  • Lithium- new SOP and guidance for monitoring during COVID-19
  • Incident reporting- new SOP and near miss log including the professional duty of Candour
  • Medicines in pregnancy- valproate registry
  • Dispensing prescriptions for children
  • Learn from patient safety events (LFPSE) Service
  • COVID-19: Yellow Card reporting including COVID-19 vaccines
  • Reporting patient safety incidents and professional duty of candour
  • Relevant links & signposting
  • Contact your MSO

Number of patient safety incidents during Q1 of 2021

Overall, there was a 6% decrease in the number of incidents reported during Q1 2021, compared to Q4 2020. This is a significant reduction in the overall number of incidents being reported during the COVID-19 pandemic. This may be due to the increased workload and pressure on pharmacy teams due to COVID-19 pandemic, whereby pharmacy teams may not be prioritising reporting of patient safety incidents, or due to other, as yet unknown, reasons.

Summary of key findings from analysis of patient safety incidents reported during Q1 2021

  • Overall, there was a 6% decrease in the number of incidents reported during Q1 2021, compared to Q4 2020.
  • 95% of incidents reported originated from the pharmacy
  • 3% of errors reported were prescribing errors – this is an increase of 1% compared to the number of incidents reported during Q4 2020
  • The most common type of incident reported during Q1 was ‘dispensing error’, which accounted for 85% of all reported incidents.
  • Delivery/collection errors accounted for 9% of the incidents reported; this is the same as Q4 2020.
  • The main categories of errors reported were those involving medication errors such as wrong drug/medicine, strength or formulation, these accounted for 67% of errors reported – this is a 1% increase from Q4 2020
  • The degree of harm caused to patients reported as ‘none’ (65%) and ‘near miss’ (20%) continues to make up the majority of the reports.
  • There was a 5% decrease in the incidents involving self checking compared to Q4 2020. This accounted for 7% of errors reported.
  • The main contributing factor continues to be ‘work and environment factors’ (41%) and LASA (22%).
  • LASA errors — 2% of all reported LASA errors involved gabapentin and pregabalin.

 

MSO q1 2021
Origin of patient safety incidents during Q1 of 2021

 

MSO q1 2021
Medication error categories and incidents reported during Q1 of 2021

 

MSO q1 2021
Contributing factors to patient safety incidents during Q1 of 2021

 

Important reminder

During the coronavirus (COVID-19) pandemic, since March 2020, there has been a significant decrease in the number of patient safety incidents being reported.  During this unprecedented time, we appreciate you are currently extremely busy with a massively increased workload. Pharmacies have had to adjust to new ways of working due to the COVID-19 pandemic.  However, patient safety incidents may occur in the course of your practice.

  • Please continue to manage and report all patient safety incidents in line with your pharmacy process
  • This includes completing the recording of the incident details carefully and fully

NPA patient safety resources

The full range of the NPA patient safety resources can be accessed on the NPA website: www.npa.co.uk/services-and-support/patientsafety

Contact the Pharmacy Services team for further advice and support:

  • Telephone: 01727891800 (Mon-Fri 9am to 6pm, Sat 9am to 1pm)
  • Email: [email protected]

 

Topics:
Advice & Support
Patient Safety
England
Pharmacy Owner / Director
Superintendent / Deputy Superintendent Pharmacist
LPC Representative

You might also like...

Today's top reads

Sign up to stay up to date

Subscribe

Why not become a member?

Find out more

Looking for a resource?

Read More
​
FOLLOW US
@NPA1921
National Pharmacy Association
National Pharmacy Association
CONTACT US
InPharmacy
Tel: (+44) 01727 858687
​

NPA

About NPA
Become a member
Services & Support
Events

Information

Privacy Policy
Terms & Conditions
Cookie Policy
Sign in or create an account

Get in touch

Contact us
Advertise with us
Write for InPharmacy

General

Pharmacy Careers
Business Partner
Insurance
Representing You

NPA InPharmacy Logotype

© 2022 • InPharmacy is produced by Redactive Media Group. All rights reserved. Reproduction of any part is not allowed without written permission.

Redactive Media Group Ltd, 71-75 Shelton Street, London WC2H 9JQ

 

 

  • Sign in
  • Create account
  • Business Support & Development
  • Learning & Development
  • Advice & Support
  • Insurance
  • Membership
  • Representing You
  • ADVICE AND SUPPORT
    • Key Notes
    • Patient Safety
    • Regulations and Legislation
    • Diary Dates
    • Pharmacy Services
  • BUSINESS SUPPORT & DEVELOPMENT
    • Technology & Data
    • Employment Law & HR
    • Health & Safety
    • Business Operations
    • Recommended Partners
  • LEARNING & DEVELOPMENT
    • Professional Development
    • You and Your Pharmacy Team
    • New Training Initiatives
  • INSURANCE
    • Business Insurance
    • Personal Insurance
    • Professional Indemnity
  • REPRESENTING YOU
    • Campaigns and lobbying
    • Opinions & Ideas